In pediatrics, asthma is a potentially deadly condition that can be difficult to stay on top of. Every year, billions of dollars are spent on the hospitalization of children with asthma. A large component of this cost, and risk, are acute asthma flares. Although they can be treated effectively by adjusting medications, there is a lack of monitoring tools that accurately identify flares early enough to prevent hospitalization, making it difficult for families to interpret symptoms and status of the disease.
The California-based startup Tueo Health has developed a sensor that resides in a child’s bedroom and can accurately detect an acute asthma flare at a very early stage. The non-contact, under-the-mattress sensor passively measures key physiologic parameters, objectively measuring the status of the condition. The sensor data is processed and made available in an easy-to-understand accompanying app, which help parents interpret symptoms, who in conjunction with the patient's medical team can adjust medication to prevent the serious consequences of acute flares.
Asthma is the most common chronic condition in children, and the third-ranking cause of hospitalization. The innovative, non-intrusive sensor developed by Tueo Health enhance asthma care, helping parents successfully manage the disease and record frequency and objectively record frequency and severity of symptoms. And in cases of worsening control of flares, the app include contact with trained asthma educators who engage and guide families through the next steps. This not only help support families to improve patient outcomes, but could significantly reduce costs associated with asthma and acute flares, while fitting within the existing management framework.
Tueo Health emerged from the Stanford's Biodesign Fellowship that aim to boost entrepreneurship in digital health and medical devices. The startup was also a semifinalist of the Medtech Innovator Competition, where they underwent a four month virtual accelerator before attending AdvaMed 2016.